Berta Ponsati Selected Research

Berta Ponsati Research Topics

5	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2023 - 07/2013
4	Neoplasms (Cancer) 10/2022 - 11/2018
4	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 11/2018
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 01/2019
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
1	Osteoporosis 04/2024
1	Hemorrhage 06/2023
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Neuroblastoma 10/2022
1	Rhabdomyosarcoma 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Glioma (Gliomas) 01/2019
1	Diabetes Mellitus 07/2013
1	Pain (Aches) 06/2012
1	Neuralgia (Stump Neuralgia) 06/2012
1	Osteosarcoma (Osteogenic Sarcoma) 06/2012

5	Peptides (Polypeptides)IBA 04/2024 - 06/2012
5	Retinaldehyde (Retinal)IBA 06/2023 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 04/2020 - 11/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 11/2018
3	AntigensIBA 01/2019 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2012
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019 - 01/2019
2	ProteomeIBA 01/2019 - 11/2018
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019 - 01/2019
1	Generic DrugsIBA 04/2024
1	Teriparatide (Parathar)FDA Link 04/2024
1	ADAM ProteinsIBA 10/2022
1	IntegrinsIBA 10/2022
1	integrin alpha9IBA 10/2022
1	cortistatinIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	HLA-A*24:02 antigenIBA 01/2019
1	VaccinesIBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 07/2013
1	Ophthalmic Solutions (Eye Drops)IBA 07/2013
1	Streptozocin (Streptozotocin)FDA Link 07/2013
1	Freund's AdjuvantIBA 06/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2012
1	palmitoyl- glutamyl- glutamyl- methionyl- glutaminyl- arginyl- argininamideIBA 06/2012
1	Ion Channels (Ion Channel)IBA 06/2012
1	Analgesics (Analgesic Drugs)IBA 06/2012
1	Calcitonin Gene-Related PeptideIBA 06/2012